Astragalus for Kidney Health

Research suggests that Astragalus and its derived compounds may offer protective effects for kidney health, with studies pointing to multiple potential mechanisms including reducing inflammation, oxidative stress, fibrosis, and cell death in kidney tissue. The available evidence includes a 2025 mechanistic review examining how calycosin, a natural compound found in Astragalus, may interact with several molecular pathways relevant to kidney disease progression, and an uncontrolled clinical study of 75 chronic kidney disease patients taking an Astragalus-based formulation for six months, which reported meaningful improvements in kidney function measures alongside laboratory findings suggesting anti-fibrotic activity. Both studies point in a supportive direction, but the evidence base remains limited in important ways — the clinical study lacked a control group, making it difficult to attribute improvements solely to the treatment, and the mechanistic review synthesizes laboratory and preclinical findings that have not yet been fully validated in rigorous human trials. Readers should be aware that while this early research is encouraging, well-designed randomized controlled trials are needed before stronger conclusions can be drawn about Astragalus supplementation and kidney health.